OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
Simon P. Langdon, C. Simon Herrington, Robert L. Hollis, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1647-1647
Open Access | Times Cited: 85
Simon P. Langdon, C. Simon Herrington, Robert L. Hollis, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1647-1647
Open Access | Times Cited: 85
Showing 26-50 of 85 citing articles:
Sex-specific outcomes in cancer therapy: the central role of hormones
Parisa Bakhshi, Jim Q. Ho, Saeid Zanganeh
Frontiers in Medical Technology (2024) Vol. 6
Open Access | Times Cited: 3
Parisa Bakhshi, Jim Q. Ho, Saeid Zanganeh
Frontiers in Medical Technology (2024) Vol. 6
Open Access | Times Cited: 3
Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer—What Can We Learn from Breast Cancer?
Tine Ottenbourgs, Els Van Nieuwenhuysen
Cancers (2024) Vol. 16, Iss. 10, pp. 1862-1862
Open Access | Times Cited: 3
Tine Ottenbourgs, Els Van Nieuwenhuysen
Cancers (2024) Vol. 16, Iss. 10, pp. 1862-1862
Open Access | Times Cited: 3
Advances in immune regulation of the G protein-coupled estrogen receptor
Hanzhi Dong, Xiaoqiang Zeng, Jiawei Xu, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112369-112369
Open Access | Times Cited: 3
Hanzhi Dong, Xiaoqiang Zeng, Jiawei Xu, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112369-112369
Open Access | Times Cited: 3
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2
Minqian Shen, Mengyang Xu, Fanyi Zhong, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 455-455
Open Access | Times Cited: 20
Minqian Shen, Mengyang Xu, Fanyi Zhong, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 455-455
Open Access | Times Cited: 20
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion
Angelo Cagnacci, Paola Villa, G. Grassi, et al.
Climacteric (2024) Vol. 28, Iss. 1, pp. 4-14
Closed Access | Times Cited: 2
Angelo Cagnacci, Paola Villa, G. Grassi, et al.
Climacteric (2024) Vol. 28, Iss. 1, pp. 4-14
Closed Access | Times Cited: 2
MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers
Tushar Singh Barwal, Uttam Sharma, Sonali Bazala, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4072-4072
Open Access | Times Cited: 15
Tushar Singh Barwal, Uttam Sharma, Sonali Bazala, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4072-4072
Open Access | Times Cited: 15
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
Aeman Zahra, Qiduo Dong, Marcia Hall, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1979-1979
Open Access | Times Cited: 15
Aeman Zahra, Qiduo Dong, Marcia Hall, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1979-1979
Open Access | Times Cited: 15
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
Robert L. Hollis, Bárbara Stanley, John P. Thomson, et al.
npj Precision Oncology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 15
Robert L. Hollis, Bárbara Stanley, John P. Thomson, et al.
npj Precision Oncology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 15
RETRACTED ARTICLE: Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway
Peng Wang, Yuanjing Hu, Pengpeng Qu, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1931-1941
Open Access | Times Cited: 10
Peng Wang, Yuanjing Hu, Pengpeng Qu, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1931-1941
Open Access | Times Cited: 10
Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis
Chun Wai Ng, Kwong‐Kwok Wong
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Chun Wai Ng, Kwong‐Kwok Wong
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
Oliver Hoffmann, Manuel Regenauer, Bastian Czogalla, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2279-2279
Open Access | Times Cited: 9
Oliver Hoffmann, Manuel Regenauer, Bastian Czogalla, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2279-2279
Open Access | Times Cited: 9
Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low‐grade ovarian carcinoma
Cynthia S. E. Hendrikse, Phyllis van der Ploeg, Nienke M. A. van de Kruis, et al.
Cancer (2023) Vol. 129, Iss. 9, pp. 1361-1371
Open Access | Times Cited: 5
Cynthia S. E. Hendrikse, Phyllis van der Ploeg, Nienke M. A. van de Kruis, et al.
Cancer (2023) Vol. 129, Iss. 9, pp. 1361-1371
Open Access | Times Cited: 5
Estrogen Receptor Signaling in Cancer
Simon P. Langdon
Cancers (2020) Vol. 12, Iss. 10, pp. 2744-2744
Open Access | Times Cited: 14
Simon P. Langdon
Cancers (2020) Vol. 12, Iss. 10, pp. 2744-2744
Open Access | Times Cited: 14
Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen
Alexandra Varga, Éva Márton, Arnold Markovics, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2060-2060
Open Access | Times Cited: 8
Alexandra Varga, Éva Márton, Arnold Markovics, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2060-2060
Open Access | Times Cited: 8
Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis
Alice Pierre, Anne Mayeur, Clémentine Marie, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 5046-5046
Open Access | Times Cited: 11
Alice Pierre, Anne Mayeur, Clémentine Marie, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 5046-5046
Open Access | Times Cited: 11
The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?
Т. А. Богуш, А. А. Башарина, Е. А. Богуш, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 5, pp. 2047-2053
Closed Access | Times Cited: 11
Т. А. Богуш, А. А. Башарина, Е. А. Богуш, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 5, pp. 2047-2053
Closed Access | Times Cited: 11
Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy
Sadia Sarwar, Abir Alamro, Fazlul Huq, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 8
Sadia Sarwar, Abir Alamro, Fazlul Huq, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 8
Endocrine therapy resistance: what we know and future directions
David Musheyev, Anya Alayev
Exploration of Targeted Anti-tumor Therapy (2022), pp. 480-496
Open Access | Times Cited: 8
David Musheyev, Anya Alayev
Exploration of Targeted Anti-tumor Therapy (2022), pp. 480-496
Open Access | Times Cited: 8
Estrogen receptor α mediates alternariol-induced apoptosis and modulation of the invasiveness of ovarian cancer cells
Marta Justyna Kozieł, Dominika Ewa Habrowska‐Górczyńska, Kinga Anna Urbanek, et al.
Toxicology Letters (2023) Vol. 386, pp. 9-19
Closed Access | Times Cited: 4
Marta Justyna Kozieł, Dominika Ewa Habrowska‐Górczyńska, Kinga Anna Urbanek, et al.
Toxicology Letters (2023) Vol. 386, pp. 9-19
Closed Access | Times Cited: 4
17β-hydroxysteroid dehydrogenase type 1 improves survival in serous epithelial ovarian tumors
E. Pedernera, Flavia Morales-Vásquez, María J. Gómora, et al.
Endocrine Connections (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 4
E. Pedernera, Flavia Morales-Vásquez, María J. Gómora, et al.
Endocrine Connections (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 4
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature
Marine Aubert, Laurent Mathiot, Hélène Vegas, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e910-e917
Open Access | Times Cited: 1
Marine Aubert, Laurent Mathiot, Hélène Vegas, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e910-e917
Open Access | Times Cited: 1
The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer
Sushil Kumar Jaiswal, Kevin Fedkenheuer, Ronak Khamar, et al.
Cancer Letters (2024) Vol. 608, pp. 217129-217129
Open Access | Times Cited: 1
Sushil Kumar Jaiswal, Kevin Fedkenheuer, Ronak Khamar, et al.
Cancer Letters (2024) Vol. 608, pp. 217129-217129
Open Access | Times Cited: 1
PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
Kamila Kozłowska-Tomczyk, Norbert Borski, Paulina Głód, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Kamila Kozłowska-Tomczyk, Norbert Borski, Paulina Głód, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Examining the relationship between per-and polyfluoroalkyl substances and breast, colorectal, prostate, and ovarian cancers: a meta-analysis
Ahmad Habibian, Nima Rastegar‐Pouyani, Nader Rahimi Kakavandi, et al.
Critical Reviews in Toxicology (2024), pp. 1-15
Closed Access | Times Cited: 1
Ahmad Habibian, Nima Rastegar‐Pouyani, Nader Rahimi Kakavandi, et al.
Critical Reviews in Toxicology (2024), pp. 1-15
Closed Access | Times Cited: 1
